MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/gim.2012.44

Медицинская библиотека · Genetics in medicine : official journal of the American College of Medical Genetics · 2012

The emerging phenotype of long-term survivors with infantile Pompe disease.

Prater Sean N, Banugaria Suhrad G, DeArmey Stephanie M, Botha Eleanor G, Stege Erin M, Case Laura E, Jones Harrison N, Phornphutkul Chanika, Wang Raymond Y, Young Sarah P, Kishnani Priya S

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: Enzyme replacement therapy with alglucosidase alfa for infantile Pompe disease has improved survival creating new management challenges. We describe an emerging phenotype in a retrospective review of long-term survivors.

METHODS

Inclusion criteria included ventilator-free status and age ≤6 months at treatment initiation, and survival to age ≥5 years. Clinical outcome measures included invasive ventilator-free survival and parameters for cardiac, pulmonary, musculoskeletal, gross motor, and ambulatory status; growth; speech, hearing, and swallowing; and gastrointestinal and nutritional status.

RESULTS

Eleven of 17 patients met study criteria. All were cross-reactive immunologic material-positive, alive, and invasive ventilator-free at most recent assessment, with a median age of 8.0 years (range: 5.4-12.0 years). All had marked improvements in cardiac parameters. Commonly present were gross motor weakness, motor speech deficits, sensorineural and/or conductive hearing loss, osteopenia, gastroesophageal reflux, and dysphagia with aspiration risk. Seven of 11 patients were independently ambulatory and four required the use of assistive ambulatory devices. All long-term survivors had low or undetectable anti-alglucosidase alfa antibody titers.

CONCLUSION

Long-term survivors exhibited sustained improvements in cardiac parameters and gross motor function. Residual muscle weakness, hearing loss, risk for arrhythmias, hypernasal speech, dysphagia with risk for aspiration, and osteopenia were commonly observed findings.

Для цитирования: Prater Sean N, Banugaria Suhrad G, DeArmey Stephanie M, Botha Eleanor G, Stege Erin M, Case Laura E, Jones Harrison N, Phornphutkul Chanika, Wang Raymond Y, Young Sarah P, Kishnani Priya S. The emerging phenotype of long-term survivors with infantile Pompe disease.. Genetics in medicine : official journal of the American College of Medical Genetics. 2012. DOI: 10.1038/gim.2012.44.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.